NCT01892618View on ClinicalTrials.gov

Pneumococcal Vaccine in Untreated CLL Patients

PHASE3CompletedINTERVENTIONAL
Enrollment

134

Participants

Timeline

Start Date

August 31, 2013

Primary Completion Date

December 31, 2015

Study Completion Date

December 31, 2015

Conditions
Chronic Lymphocytic Leukemia
Interventions
DRUG

Prevenar 13

13-valent pneumococcal conjugated vaccine

DRUG

Pneumovax

23-valent pneumococcal polysaccharide vaccine

Trial Locations (1)

14186

Karolinska University Hospital, Stockholm

All Listed Sponsors
lead

Karolinska University Hospital

OTHER

NCT01892618 - Pneumococcal Vaccine in Untreated CLL Patients | Biotech Hunter | Biotech Hunter